Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Market Dynamics
Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.
Key features of the study:
This report provides in-depth analysis of premature ejaculation treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global premature ejaculation treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics
The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market
Detailed Segmentation:
Global Premature Ejaculation Treatment Market, By Drug Type :
Selective Serotonin Reuptake Inhibitors (SSRIs)
Dapoxetine
Others
Phosphodiesterase Type 5 (PDE5) Inhibitors
Zertane
Others
Topical Anesthetics
Others
Global Premature Ejaculation Treatment Market, By Route of Administration:
Oral
Topical
Global Premature Ejaculation Treatment Market, By Dosage Form:
Pills
Spray
Others
Global Premature Ejaculation Treatment Market, By Distribution Channel:
Hospitals
Online Pharmacies
Retail Pharmacies
Global Premature Ejaculation Treatment Market, By Geography:
North America
Drug Type:
Selective Serotonin Reuptake Inhibitors (SSRIs)
Dapoxetine
Others
Phosphodiesterase Type 5 (PDE5) Inhibitors
Zertane
Others
Topical Anesthetics
Others
By Route of Administration:
Oral
Topical
By Dosage Form
Pills
Spray
Others
By Distribution Channel
Hospitals
Online Pharmacies
Retail Pharmacies
By Country:
U.S.
Canada
Europe
Drug Type:
Selective Serotonin Reuptake Inhibitors (SSRIs)
Dapoxetine
Others
Phosphodiesterase Type 5 (PDE5) Inhibitors
Zertane
Others
Topical Anesthetics
Others
By Route of Administration:
Oral
Topical
By Dosage Form
Pills
Spray
Others
By Distribution Channel
Hospitals
Online Pharmacies
Retail Pharmacies
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Drug Type:
Selective Serotonin Reuptake Inhibitors (SSRIs)
Dapoxetine
Others
Phosphodiesterase Type 5 (PDE5) Inhibitors
Zertane
Others
Topical Anesthetics
Others
By Route of Administration:
Oral
Topical
By Dosage Form
Pills
Spray
Others
By Distribution Channel
Hospitals
Online Pharmacies
Retail Pharmacies
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Drug Type:
Selective Serotonin Reuptake Inhibitors (SSRIs)
Dapoxetine
Others
Phosphodiesterase Type 5 (PDE5) Inhibitors
Zertane
Others
Topical Anesthetics
Others
By Route of Administration:
Oral
Topical
By Dosage Form
Pills
Spray
Others
By Distribution Channel
Hospitals
Online Pharmacies
Retail Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Drug Type:
Selective Serotonin Reuptake Inhibitors (SSRIs)
Dapoxetine
Others
Phosphodiesterase Type 5 (PDE5) Inhibitors
Zertane
Others
Topical Anesthetics
Others
By Route of Administration:
Oral
Topical
By Dosage Form
Pills
Spray
Others
By Distribution Channel
Hospitals
Online Pharmacies
Retail Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
Drug Type:
Selective Serotonin Reuptake Inhibitors (SSRIs)
Dapoxetine
Others
Phosphodiesterase Type 5 (PDE5) Inhibitors
Zertane
Others
Topical Anesthetics
Others
By Route of Administration:
Oral
Topical
By Dosage Form
Pills
Spray
Others
By Distribution Channel
Hospitals
Online Pharmacies
Retail Pharmacies
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Regent Pacific Group Limited *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Menarini Group
Furiex Pharmaceuticals, Inc.
Absorption Pharmaceuticals, LLC
Ampio Pharmaceuticals, Inc.
Aytu BioScience
NeuroHealing Pharmaceuticals Inc.
Dong-A Pharmaceutical Co., Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Drug Type
o Market Snippet, By Route of Administration
o Market Snippet, By Dosage Form
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o PEST Analysis
o Pipeline Analysis
o Product Approval
o Product Launch
o Collaboration-Acquisition
o Porter's Five Forces Analysis
4. Global Premature Ejaculation Treatment Market, By Drug Type, 2016 - 2026 (US$ Bn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Selective Serotonin Reuptake Inhibitors (SSRIs)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
o Segment Trends
o Dapoxetine
o Others
o Phosphodiesterase Type 5 (PDE5) Inhibitors
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
o Segment Trends
o Zertane
o Others
o Topical Anesthetics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2016 - 2026 (US$ Bn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Oral
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
o Topical
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
6. Global Premature Ejaculation Treatment Market, Dosage Form, 2016 - 2026 (US$ Bn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Pills
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
o Spray
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2016 - 2026 (US$ Bn)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Hospitals
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
o Online Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Bn)
8. Global Premature Ejaculation Treatment Market, By Region, 2016 - 2026 (US$ Bn)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, For Regions, 2017-2026
o North America
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
o Central Africa
o South Africa
o North Africa
o Middle East
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Dosage Form, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Bn)
o Market Size and Forecast, By Country, 2016 - 2026 (US$ Bn)
o GCC
o Israel
o Rest of Middle East
9. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Regent Pacific Group Limited
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Menarini Group
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Furiex Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Absorption Pharmaceuticals, LLC
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Ampio Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Aytu BioScience
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o NeuroHealing Pharmaceuticals Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
o Dong-A Pharmaceutical Co., Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
10. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 37 market data tables and 40 figures on "Premature Ejaculation Treatment Market - Global forecast to 2025".
Request Discount 
Inquire Before Buy
